Common use of Emerging Growth Company Clause in Contracts

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 62 contracts

Samples: Sales Agreement (Entrada Therapeutics, Inc.), Sales Agreement (iTeos Therapeutics, Inc.), Sales Agreement (AVITA Medical, Inc.)

AutoNDA by SimpleDocs

Emerging Growth Company. The As of the date of this Agreement, the Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 5 contracts

Samples: Common Stock (Kymera Therapeutics, Inc.), Sales Agreement (Passage BIO, Inc.), Sales Agreement (Atreca, Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” ”, as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen the Agents promptly upon the Company ceasing to be an emerging growth company.

Appears in 4 contracts

Samples: Sales Agreement (Electrameccanica Vehicles Corp.), Sales Agreement (Electrameccanica Vehicles Corp.), Sales Agreement (Electrameccanica Vehicles Corp.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen the Agents promptly upon the Company ceasing to be an emerging growth company.

Appears in 3 contracts

Samples: Sales Agreement (Beyond Air, Inc.), Sales Agreement (Beyond Air, Inc.), Sales Agreement (Kura Oncology, Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities ActAct (an “Emerging Growth Company”). The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Sales Agreement (Elevation Oncology, Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company; provided, that the Company shall not be required to notify Cowen when it ceases to be an emerging growth company on December 31, 2022 (i.e., the last day of the fiscal year of the Company following the fifth anniversary of the date of the first sale of common equity securities of the Company pursuant to an effective registration statement under the Securities Act).

Appears in 1 contract

Samples: Sales Agreement (Aadi Bioscience, Inc.)

Emerging Growth Company. The Company has been and is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Sales Agreement (Singular Genomics Systems, Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities 1933 Act. The Company agrees to notify Cowen the Purchaser promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Purchase Agreement (Adaptimmune Therapeutics PLC)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a2(a)(19) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Sales Agreement (Ambrx Biopharma Inc.)

AutoNDA by SimpleDocs

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Sales Agreement (Nkarta, Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a2(a)(19) of the Securities Act. The Company agrees to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Common Stock (Cue Health Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities 1933 Act. The Company agrees to notify Cowen the Representatives promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Underwriting Agreement (Adaptimmune Therapeutics PLC)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company agrees to use commercially reasonable efforts to notify Cowen promptly upon the Company ceasing to be an emerging growth company.

Appears in 1 contract

Samples: Sales Agreement (Vicarious Surgical Inc.)

Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act. The Company will no longer be an emerging growth company as of December 31, 2022. The Company agrees to notify Cowen promptly upon if the Company ceasing ceases to be an emerging growth companycompany prior to December 31, 2022.

Appears in 1 contract

Samples: Common Stock Sales Agreement (Jounce Therapeutics, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!